Found 57 clinical trials
COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in Children
, cellular immune populations, autoantibodies, as well as host genetic markers.
- 0 views
- 01 May, 2022
- 1 location
Registry Study on Patient Characteristics Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
all participating centers (completeness) To perform timely analyses of disease-related genetic markers (incidences, treatment recommendations) To assess patient and family history
- 38 views
- 09 Oct, 2021
- 85 locations
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
genetic markers have been associated with sarcoidosis, none fully explain individual susceptibility or clinical course variability, strongly implicating the environment and epigenetics. We have the
- 115 views
- 23 Feb, 2022
- 1 location
Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort
different nature(autoantibodies, genetic markers of "kidney damage") looking atdiagnostic and/orprognostic features. In recent years, several biomarkers have been developed that seek to find an association
- 7 views
- 07 May, 2021
- 1 location
COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Prospective cohort study of COVID-19 infection among children in Norway.
- 0 views
- 23 Mar, 2022
- 1 location
Vulnerability for Alcohol Use Disorder After ACE: the Role of Stress Sensitivity, Emotion Processing, Cue Reactivity and Cognitive Functions in Relapse Risk
Adverse childhood experiences (ACE) and their relation to the development of an alcohol use disorder (AUD) will be measured with fMRI.
- 0 views
- 28 Oct, 2022
- 1 location
Clinical Functional Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection
The purpose of the program. To determine the clinical, functional, immunological, and genetic factors affecting the severity of the course of acute coronavirus infection COVID-19 and PostCovid syndrome, in order to develop management tactics for such patients to reduce the risk of complications and disability.
- 0 views
- 11 Aug, 2021
- 1 location